Hongyong Yang
Known title: VP and GM Fuel Syst. Asia PacCIK: 0002027839
Associated companies
Transaction History
| PHIN | ▲ Buy | Grant | 4 | $0 | 6/23/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 6 | $0 | 3/20/2026 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 2,003 | — | 2/27/2026 | View on chart |
| PHIN | ▼ Sell | Other | 2,003 | $145K | 2/27/2026 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 1,130 | — | 2/27/2026 | View on chart |
| PHIN | ▼ Sell | Other | 1,130 | $82K | 2/27/2026 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 1,648 | — | 2/27/2026 | View on chart |
| PHIN | ▼ Sell | Other | 1,648 | $120K | 2/27/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 1,197 | $0 | 2/9/2026 | View on chart |
| PHIN | ▼ Sell | Open Market | 893 | $47K | 11/19/2025 | View on chart |
| PHIN | ▼ Sell | Other | 2,003 | $99K | 2/28/2025 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 2,158 | — | 2/28/2025 | View on chart |
| PHIN | ▼ Sell | Other | 2,158 | $106K | 2/28/2025 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 2,003 | — | 2/28/2025 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 1,130 | — | 2/28/2025 | View on chart |
| PHIN | ▼ Sell | Other | 1,130 | $56K | 2/28/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.